M
Mohanram Narayanan
Researcher at Texas A&M Health Science Center College of Medicine
Publications - 7
Citations - 582
Mohanram Narayanan is an academic researcher from Texas A&M Health Science Center College of Medicine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 4 publications receiving 342 citations.
Papers
More filters
Journal ArticleDOI
Cell-Free DNA and Active Rejection in Kidney Allografts
Roy D. Bloom,Jonathan S. Bromberg,Emilio D. Poggio,Suphamai Bunnapradist,Anthony Langone,Puneet Sood,Arthur J. Matas,Shikha Mehta,Roslyn B. Mannon,Asif Sharfuddin,Bernard Fischbach,Mohanram Narayanan,Stanley C. Jordan,Stanley C. Jordan,David J. Cohen,Matthew R. Weir,D. Hiller,Preethi Prasad,Robert Woodward,Marica Grskovic,John J. Sninsky,J. Yee,Daniel C. Brennan +22 more
TL;DR: Donor-derived cell-free DNA may be used to assess allograft rejection and injury; dd-cfDNA levels <1% reflect the absence of active rejection (T cell-mediated type ≥IB or ABMR) and levels >1% indicate a probability of active rejected.
Journal ArticleDOI
Immune Dysfunction and Risk of Infection in Chronic Kidney Disease.
TL;DR: Measures aimed at attenuating the immune abnormalities in chronic kidney disease/end-stage renal disease should be an area of focused research as this could potentially lead to a better understanding and development of therapies that could reduce the disastrously high death rate in this patient population.
Journal ArticleDOI
Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications
Jonathan S. Bromberg,Daniel C. Brennan,Emilio D. Poggio,Suphamai Bunnapradist,Anthony Langone,Puneet Sood,Arthur J. Matas,Roslyn B. Mannon,Shikha Mehta,Asif Sharfuddin,Bernard Fischbach,Mohanram Narayanan,Stanley C. Jordan,Stanley C. Jordan,David J. Cohen,Ziad S. Zaky,D. Hiller,Robert Woodward,Marica Grskovic,John J. Sninsky,J. Yee,Roy D. Bloom +21 more
TL;DR: The biological variation and clinical reference intervals of dd-cfDNA in renal transplant recipients are established by using an analytically validated assay that has a CV of 6.8 and a serial increase of up to 61% in level in a patient may be attributable to biological variation.
Journal ArticleDOI
The Many Faces of Infection in CKD: Evolving Paradigms, Insights, and Novel Therapies.
Journal ArticleDOI
Management of Metabolic Acidosis in Chronic Kidney Disease: Past, Present, and Future Direction.
TL;DR: The aim of the present review is to explore the various intervention strategies that increase or normalize serum [HCO3-] in patients with CKD-associated MA or low normal serum[HCO2-] that may further slow progression of CKD.